Ask AI
ProCE Banner Activity

Pressure Points in Resistant Hypertension: Pioneering Pathways to Control the Uncontrollable 

Slideset

Expert-curated slides on the pathophysiology of resistant hypertension and current evidence for emerging therapies, including their efficacy, safety, and clinical utility, to help you address previously unmet patient needs.

Released: August 29, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from AstraZeneca Pharmaceuticals.

AstraZeneca Pharmaceuticals

Learning Objectives

Upon completion of this activity, participants should be able to: 

  • Identify true resistant HTN and the clinical implications of delayed recognition or suboptimal management

  • Discuss the scientific and clinical basis for novel therapies targeting different pathophysiological pathways as a strategy to improve blood pressure control

  • Develop evidence-based, personalized treatment plans that integrate the potential clinical utility of novel agents to address unmet needs and advance the management of resistant HTN